Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.07063361 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.07063361 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.95809893 |
4 | response to type I interferon (GO:0034340) | 6.35620791 |
5 | type I interferon signaling pathway (GO:0060337) | 6.32901856 |
6 | cellular response to type I interferon (GO:0071357) | 6.32901856 |
7 | regulation of T cell tolerance induction (GO:0002664) | 6.11609637 |
8 | positive regulation of interferon-alpha production (GO:0032727) | 5.55565836 |
9 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.29384427 |
10 | regulation of interferon-alpha production (GO:0032647) | 5.21175068 |
11 | natural killer cell mediated immunity (GO:0002228) | 5.20368541 |
12 | natural killer cell mediated cytotoxicity (GO:0042267) | 5.20368541 |
13 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.19824452 |
14 | regulation of tolerance induction (GO:0002643) | 5.18247859 |
15 | regulation of chronic inflammatory response (GO:0002676) | 4.93419433 |
16 | kynurenine metabolic process (GO:0070189) | 4.93110184 |
17 | positive regulation of tolerance induction (GO:0002645) | 4.88697150 |
18 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.87487333 |
19 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.80170973 |
20 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.79580242 |
21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.77678758 |
22 | tryptophan catabolic process (GO:0006569) | 4.68174333 |
23 | indole-containing compound catabolic process (GO:0042436) | 4.68174333 |
24 | indolalkylamine catabolic process (GO:0046218) | 4.68174333 |
25 | positive regulation of antigen processing and presentation (GO:0002579) | 4.64199978 |
26 | negative regulation of viral genome replication (GO:0045071) | 4.58272594 |
27 | response to interferon-alpha (GO:0035455) | 4.57392732 |
28 | cellular response to exogenous dsRNA (GO:0071360) | 4.38388897 |
29 | negative regulation of interleukin-12 production (GO:0032695) | 4.38070707 |
30 | immunoglobulin mediated immune response (GO:0016064) | 4.31963933 |
31 | negative regulation of interleukin-10 production (GO:0032693) | 4.30961559 |
32 | cellular response to interferon-beta (GO:0035458) | 4.28706740 |
33 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.19750324 |
34 | eosinophil chemotaxis (GO:0048245) | 4.19573430 |
35 | regulation of interleukin-12 production (GO:0032655) | 4.15123848 |
36 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.14925572 |
37 | regulation of antigen processing and presentation (GO:0002577) | 4.13799638 |
38 | response to interferon-beta (GO:0035456) | 4.12249198 |
39 | cellular response to interferon-alpha (GO:0035457) | 4.10182588 |
40 | superoxide anion generation (GO:0042554) | 4.07846453 |
41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.05997945 |
42 | cellular response to interferon-gamma (GO:0071346) | 3.99989520 |
43 | regulation of macrophage chemotaxis (GO:0010758) | 3.95861695 |
44 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.93790108 |
45 | positive regulation of type 2 immune response (GO:0002830) | 3.93761510 |
46 | response to interferon-gamma (GO:0034341) | 3.93081426 |
47 | regulation of T-helper cell differentiation (GO:0045622) | 3.92923340 |
48 | cellular response to virus (GO:0098586) | 3.92656384 |
49 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.90649861 |
50 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.87512009 |
51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86731278 |
52 | regulation of type 2 immune response (GO:0002828) | 3.84001894 |
53 | lymphocyte chemotaxis (GO:0048247) | 3.81883000 |
54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.80363558 |
55 | modulation by symbiont of host defense response (GO:0052031) | 3.80363558 |
56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.80363558 |
57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.80363558 |
58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.80363558 |
59 | modulation by symbiont of host immune response (GO:0052553) | 3.80363558 |
60 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.79385799 |
61 | tryptophan metabolic process (GO:0006568) | 3.78378176 |
62 | dendritic cell chemotaxis (GO:0002407) | 3.75173768 |
63 | regulation of interleukin-10 production (GO:0032653) | 3.74905958 |
64 | * positive regulation of cAMP-mediated signaling (GO:0043950) | 3.72152053 |
65 | eosinophil migration (GO:0072677) | 3.71891375 |
66 | positive regulation of interferon-beta production (GO:0032728) | 3.70243213 |
67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.69823506 |
68 | T cell migration (GO:0072678) | 3.68955905 |
69 | T-helper 1 type immune response (GO:0042088) | 3.65961358 |
70 | respiratory burst (GO:0045730) | 3.60924747 |
71 | detection of other organism (GO:0098543) | 3.56755266 |
72 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.55733472 |
73 | regulation of hypersensitivity (GO:0002883) | 3.54748456 |
74 | myeloid dendritic cell differentiation (GO:0043011) | 3.50982227 |
75 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.48827066 |
76 | leukocyte mediated cytotoxicity (GO:0001909) | 3.47073982 |
77 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.46792923 |
78 | positive regulation of neutrophil migration (GO:1902624) | 3.46792923 |
79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40461768 |
80 | positive regulation of interleukin-10 production (GO:0032733) | 3.39492448 |
81 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.38768442 |
82 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.38735933 |
83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38463099 |
84 | reactive oxygen species biosynthetic process (GO:1903409) | 3.37716237 |
85 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.36324446 |
86 | regulation of T-helper 1 type immune response (GO:0002825) | 3.36119957 |
87 | detection of bacterium (GO:0016045) | 3.29478843 |
88 | NIK/NF-kappaB signaling (GO:0038061) | 3.29172368 |
89 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.27766781 |
90 | * defense response to virus (GO:0051607) | 3.27379455 |
91 | intracellular pH reduction (GO:0051452) | 3.26958336 |
92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.26184507 |
93 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.25389973 |
94 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.25021393 |
95 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.24686321 |
96 | B cell mediated immunity (GO:0019724) | 3.24535500 |
97 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.24224595 |
98 | regulation of interleukin-1 secretion (GO:0050704) | 3.20834615 |
99 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.16466389 |
100 | interferon-gamma secretion (GO:0072643) | 3.15522571 |
101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.15004205 |
102 | superoxide metabolic process (GO:0006801) | 3.14609937 |
103 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.14000756 |
104 | positive regulation of interleukin-12 production (GO:0032735) | 3.11385880 |
105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.10636864 |
106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09668103 |
107 | positive regulation of defense response to virus by host (GO:0002230) | 3.09435439 |
108 | low-density lipoprotein particle clearance (GO:0034383) | 3.08846384 |
109 | amine catabolic process (GO:0009310) | 3.08812899 |
110 | cellular biogenic amine catabolic process (GO:0042402) | 3.08812899 |
111 | negative regulation of cell killing (GO:0031342) | 3.08381975 |
112 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.08381975 |
113 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.07013336 |
114 | regulation of vitamin metabolic process (GO:0030656) | 3.05921314 |
115 | positive regulation of T cell cytokine production (GO:0002726) | 3.05615363 |
116 | detection of molecule of bacterial origin (GO:0032490) | 3.03743224 |
117 | regulation of granulocyte chemotaxis (GO:0071622) | 3.02931579 |
118 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.02278407 |
119 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.00686970 |
120 | response to host immune response (GO:0052572) | 3.00686970 |
121 | lymphocyte mediated immunity (GO:0002449) | 2.98498119 |
122 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.97389909 |
123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.96383092 |
124 | regulation of cholesterol storage (GO:0010885) | 2.95692477 |
125 | regulation of RIG-I signaling pathway (GO:0039535) | 2.94340550 |
126 | myeloid dendritic cell activation (GO:0001773) | 2.92296235 |
127 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.91128652 |
128 | defense response to protozoan (GO:0042832) | 2.89020909 |
129 | response to peptidoglycan (GO:0032494) | 2.83294252 |
130 | dendritic cell differentiation (GO:0097028) | 2.81894892 |
131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81292172 |
132 | response to muramyl dipeptide (GO:0032495) | 2.80459534 |
133 | regulation of response to interferon-gamma (GO:0060330) | 2.79232888 |
134 | positive regulation of heat generation (GO:0031652) | 2.79171559 |
135 | cell killing (GO:0001906) | 2.77673113 |
136 | negative regulation of B cell proliferation (GO:0030889) | 2.76747271 |
137 | regulation of mononuclear cell migration (GO:0071675) | 2.75372425 |
138 | neutrophil activation involved in immune response (GO:0002283) | 2.73719340 |
139 | plasma lipoprotein particle clearance (GO:0034381) | 2.72993958 |
140 | arginine catabolic process (GO:0006527) | 2.71504031 |
141 | macrophage activation involved in immune response (GO:0002281) | 2.71058610 |
142 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.70207135 |
143 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.70095234 |
144 | microglial cell activation (GO:0001774) | 2.67348793 |
145 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61080789 |
146 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58620367 |
147 | response to host (GO:0075136) | 2.58620367 |
148 | response to host defenses (GO:0052200) | 2.58620367 |
149 | pH reduction (GO:0045851) | 2.58534035 |
150 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.56626160 |
151 | regulation of fever generation (GO:0031620) | 2.56436026 |
152 | regulation of interferon-beta production (GO:0032648) | 2.54925374 |
153 | negative regulation of viral process (GO:0048525) | 2.53969119 |
154 | regulation of activation of Janus kinase activity (GO:0010533) | 2.53411354 |
155 | regulation of defense response to virus by host (GO:0050691) | 2.52015897 |
156 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.51741501 |
157 | JAK-STAT cascade (GO:0007259) | 2.49973245 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.90624867 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.81697990 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.25803721 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.18503851 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.97054114 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13801624 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.12965735 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10104574 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90101654 |
10 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90052237 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.85820021 |
12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.83417960 |
13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.63707693 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48718520 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42174955 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34954163 |
17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34572709 |
18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.34247929 |
19 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.31629655 |
20 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24414294 |
21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18121258 |
22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05512115 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00710777 |
24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90134427 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89656283 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84597045 |
27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84487505 |
28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77728266 |
29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.74171466 |
30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71286830 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63636789 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60145505 |
33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59442787 |
34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57570606 |
35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40218269 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37352250 |
37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34343688 |
38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33997232 |
39 | * EGR1_19032775_ChIP-ChIP_M12_Human | 1.33675825 |
40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32995110 |
41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29888486 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26599421 |
43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24704042 |
44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24189322 |
45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22472548 |
46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22257755 |
47 | MAF_26560356_Chip-Seq_TH1_Human | 1.11429096 |
48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10120773 |
49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09923718 |
50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09095704 |
51 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07360297 |
52 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05797102 |
53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04914144 |
54 | MYB_26560356_Chip-Seq_TH2_Human | 1.04377314 |
55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04154309 |
56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03795560 |
57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02643599 |
58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00820084 |
59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00223930 |
60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98525814 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98025830 |
62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97461282 |
63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97461282 |
64 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95177789 |
65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94497135 |
66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93497980 |
67 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91313720 |
68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90263469 |
69 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87137683 |
70 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84292808 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82409937 |
72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80928696 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79201853 |
74 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78945763 |
75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76608774 |
76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76581429 |
77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76572145 |
78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76459280 |
79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76407022 |
80 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.76296974 |
81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75312616 |
82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74868961 |
83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74037534 |
84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.73763638 |
85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73576125 |
86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.72722061 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72206755 |
88 | MYB_26560356_Chip-Seq_TH1_Human | 0.71012288 |
89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.70496179 |
90 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70428930 |
91 | UTX_26944678_Chip-Seq_JUKART_Human | 0.70363466 |
92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70175577 |
93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70138246 |
94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69891235 |
95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69281793 |
96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69218752 |
97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68859960 |
98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.67886970 |
99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67255008 |
100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67187245 |
101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67119467 |
102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66304178 |
103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.65669285 |
104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64056496 |
105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.63901978 |
106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.62928252 |
107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61629336 |
108 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.61451795 |
109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61347794 |
110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61046794 |
111 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.59813172 |
112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.59692196 |
113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58653954 |
114 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.57803957 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57548871 |
116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57436134 |
117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57143452 |
118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.56817558 |
119 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56191627 |
120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.56073891 |
121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55188706 |
122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.54414247 |
123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.53500948 |
124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.53293531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004510_myositis | 4.45215836 |
2 | MP0001835_abnormal_antigen_presentation | 4.21869109 |
3 | MP0003303_peritoneal_inflammation | 3.37105995 |
4 | MP0003724_increased_susceptibility_to | 3.17469899 |
5 | MP0009785_altered_susceptibility_to | 3.17279628 |
6 | MP0001790_abnormal_immune_system | 2.94102588 |
7 | MP0005387_immune_system_phenotype | 2.94102588 |
8 | MP0000685_abnormal_immune_system | 2.92102502 |
9 | MP0005671_abnormal_response_to | 2.78618944 |
10 | MP0003436_decreased_susceptibility_to | 2.78483159 |
11 | MP0006082_CNS_inflammation | 2.78294261 |
12 | MP0005025_abnormal_response_to | 2.70314489 |
13 | MP0005058_abnormal_lysosome_morphology | 2.66741646 |
14 | MP0009840_abnormal_foam_cell | 2.41470810 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.38637117 |
16 | MP0005000_abnormal_immune_tolerance | 2.30668559 |
17 | MP0002419_abnormal_innate_immunity | 2.30531077 |
18 | MP0002254_reproductive_system_inflammat | 2.06183406 |
19 | * MP0001800_abnormal_humoral_immune | 2.00780299 |
20 | MP0009764_decreased_sensitivity_to | 1.97473074 |
21 | MP0001533_abnormal_skeleton_physiology | 1.94684952 |
22 | * MP0002452_abnormal_antigen_presenting | 1.93826364 |
23 | * MP0002723_abnormal_immune_serum | 1.89570753 |
24 | MP0001853_heart_inflammation | 1.89055821 |
25 | MP0003448_altered_tumor_morphology | 1.88441223 |
26 | MP0003075_altered_response_to | 1.87762768 |
27 | MP0004947_skin_inflammation | 1.86002920 |
28 | MP0002139_abnormal_hepatobiliary_system | 1.84855705 |
29 | MP0005360_urolithiasis | 1.82086461 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.81911850 |
31 | MP0000604_amyloidosis | 1.78622870 |
32 | MP0003300_gastrointestinal_ulcer | 1.76882774 |
33 | MP0004858_abnormal_nervous_system | 1.71852880 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.66111407 |
35 | MP0008469_abnormal_protein_level | 1.65205314 |
36 | MP0003183_abnormal_peptide_metabolism | 1.65086759 |
37 | MP0002277_abnormal_respiratory_mucosa | 1.63412520 |
38 | MP0005464_abnormal_platelet_physiology | 1.61601459 |
39 | MP0002166_altered_tumor_susceptibility | 1.58552983 |
40 | * MP0001819_abnormal_immune_cell | 1.56101701 |
41 | MP0000343_altered_response_to | 1.51937726 |
42 | MP0005310_abnormal_salivary_gland | 1.49981140 |
43 | MP0003806_abnormal_nucleotide_metabolis | 1.49682402 |
44 | * MP0002420_abnormal_adaptive_immunity | 1.49499383 |
45 | * MP0001845_abnormal_inflammatory_respons | 1.45289550 |
46 | MP0003172_abnormal_lysosome_physiology | 1.44680015 |
47 | MP0010155_abnormal_intestine_physiology | 1.42272661 |
48 | MP0004782_abnormal_surfactant_physiolog | 1.42244973 |
49 | MP0003941_abnormal_skin_development | 1.41057898 |
50 | MP0005164_abnormal_response_to | 1.37465618 |
51 | MP0003453_abnormal_keratinocyte_physiol | 1.35426859 |
52 | MP0003186_abnormal_redox_activity | 1.29039633 |
53 | MP0003690_abnormal_glial_cell | 1.28450380 |
54 | MP0003045_fibrosis | 1.28381059 |
55 | MP0000569_abnormal_digit_pigmentation | 1.23201365 |
56 | MP0009278_abnormal_bone_marrow | 1.22808602 |
57 | MP0001851_eye_inflammation | 1.22496189 |
58 | MP0002998_abnormal_bone_remodeling | 1.20798018 |
59 | MP0005085_abnormal_gallbladder_physiolo | 1.17344407 |
60 | MP0005365_abnormal_bile_salt | 1.15330556 |
61 | MP0005451_abnormal_body_composition | 1.15104551 |
62 | MP0005167_abnormal_blood-brain_barrier | 1.11355862 |
63 | MP0000716_abnormal_immune_system | 1.09135344 |
64 | MP0009763_increased_sensitivity_to | 1.06430390 |
65 | MP0002006_tumorigenesis | 1.06371795 |
66 | MP0005397_hematopoietic_system_phenotyp | 1.03684028 |
67 | MP0001545_abnormal_hematopoietic_system | 1.03684028 |
68 | MP0010329_abnormal_lipoprotein_level | 1.02437969 |
69 | MP0000609_abnormal_liver_physiology | 1.01155142 |
70 | MP0003329_amyloid_beta_deposits | 1.00818282 |
71 | MP0005319_abnormal_enzyme/_coenzyme | 1.00231308 |
72 | MP0003705_abnormal_hypodermis_morpholog | 0.99318122 |
73 | MP0009333_abnormal_splenocyte_physiolog | 0.97975623 |
74 | MP0005166_decreased_susceptibility_to | 0.96491453 |
75 | MP0002971_abnormal_brown_adipose | 0.96335381 |
76 | MP0009115_abnormal_fat_cell | 0.96228085 |
77 | MP0010307_abnormal_tumor_latency | 0.95459645 |
78 | MP0002877_abnormal_melanocyte_morpholog | 0.94638968 |
79 | MP0002405_respiratory_system_inflammati | 0.94143625 |
80 | MP0008260_abnormal_autophagy | 0.93808092 |
81 | MP0001881_abnormal_mammary_gland | 0.91802272 |
82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91670069 |
83 | MP0002876_abnormal_thyroid_physiology | 0.91182499 |
84 | MP0010234_abnormal_vibrissa_follicle | 0.88952546 |
85 | MP0005083_abnormal_biliary_tract | 0.88351938 |
86 | MP0002398_abnormal_bone_marrow | 0.88284631 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.86916505 |
88 | MP0001873_stomach_inflammation | 0.86797002 |
89 | MP0003091_abnormal_cell_migration | 0.86736693 |
90 | MP0008775_abnormal_heart_ventricle | 0.84260898 |
91 | MP0003252_abnormal_bile_duct | 0.83635874 |
92 | MP0000858_altered_metastatic_potential | 0.83162769 |
93 | MP0003866_abnormal_defecation | 0.82232895 |
94 | MP0005248_abnormal_Harderian_gland | 0.81496937 |
95 | MP0005390_skeleton_phenotype | 0.81372878 |
96 | MP0002118_abnormal_lipid_homeostasis | 0.80570273 |
97 | MP0002429_abnormal_blood_cell | 0.80417346 |
98 | MP0000920_abnormal_myelination | 0.80252440 |
99 | MP0005076_abnormal_cell_differentiation | 0.79640154 |
100 | MP0000249_abnormal_blood_vessel | 0.79516830 |
101 | MP0010352_gastrointestinal_tract_polyps | 0.78594117 |
102 | MP0005332_abnormal_amino_acid | 0.78320440 |
103 | MP0002722_abnormal_immune_system | 0.77594930 |
104 | MP0003763_abnormal_thymus_physiology | 0.75116519 |
105 | MP0006054_spinal_hemorrhage | 0.75112481 |
106 | MP0001663_abnormal_digestive_system | 0.74102011 |
107 | MP0000465_gastrointestinal_hemorrhage | 0.73107115 |
108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71516921 |
109 | MP0002136_abnormal_kidney_physiology | 0.71515320 |
110 | MP0000689_abnormal_spleen_morphology | 0.70858854 |
111 | MP0003566_abnormal_cell_adhesion | 0.70792910 |
112 | MP0002332_abnormal_exercise_endurance | 0.70437480 |
113 | MP0008004_abnormal_stomach_pH | 0.69430731 |
114 | MP0004883_abnormal_blood_vessel | 0.69384545 |
115 | MP0005334_abnormal_fat_pad | 0.69280725 |
116 | MP0000371_diluted_coat_color | 0.68015278 |
117 | MP0005023_abnormal_wound_healing | 0.67816435 |
118 | MP0008438_abnormal_cutaneous_collagen | 0.67597791 |
119 | MP0003195_calcinosis | 0.66513931 |
120 | MP0000015_abnormal_ear_pigmentation | 0.65433295 |
121 | MP0001348_abnormal_lacrimal_gland | 0.63319851 |
122 | MP0002693_abnormal_pancreas_physiology | 0.63072793 |
123 | MP0008874_decreased_physiological_sensi | 0.62732618 |
124 | MP0002933_joint_inflammation | 0.59814619 |
125 | MP0005165_increased_susceptibility_to | 0.58161429 |
126 | MP0003828_pulmonary_edema | 0.57114760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.78229783 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.78784543 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.75697644 |
4 | Recurrent abscess formation (HP:0002722) | 5.50081605 |
5 | Chronic otitis media (HP:0000389) | 5.22640119 |
6 | Systemic lupus erythematosus (HP:0002725) | 5.00082069 |
7 | Abnormality of macrophages (HP:0004311) | 4.73560660 |
8 | Gastrointestinal infarctions (HP:0005244) | 4.69684416 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.55411721 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.49925439 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.49925439 |
12 | Tetraparesis (HP:0002273) | 4.21954109 |
13 | Recurrent skin infections (HP:0001581) | 4.10629508 |
14 | Hemoptysis (HP:0002105) | 3.93529245 |
15 | Increased cerebral lipofuscin (HP:0011813) | 3.89867103 |
16 | Nasal polyposis (HP:0100582) | 3.87032372 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.80864390 |
18 | Abnormality of the nasal mucosa (HP:0000433) | 3.74098486 |
19 | Malnutrition (HP:0004395) | 3.68520414 |
20 | Myositis (HP:0100614) | 3.62169803 |
21 | Thick nail (HP:0001805) | 3.59712780 |
22 | Gingivitis (HP:0000230) | 3.53852805 |
23 | Obstructive lung disease (HP:0006536) | 3.52398821 |
24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52398821 |
25 | Interstitial pulmonary disease (HP:0006530) | 3.46673449 |
26 | Pulmonary infiltrates (HP:0002113) | 3.46075577 |
27 | Recurrent fungal infections (HP:0002841) | 3.45121945 |
28 | Basal ganglia calcification (HP:0002135) | 3.37341393 |
29 | Complement deficiency (HP:0004431) | 3.36258536 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 3.34156216 |
31 | Loss of speech (HP:0002371) | 3.29801933 |
32 | Increased IgE level (HP:0003212) | 3.27477937 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.20569941 |
34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.20569941 |
35 | Keratoconjunctivitis sicca (HP:0001097) | 3.18017670 |
36 | Recurrent viral infections (HP:0004429) | 3.17913398 |
37 | Glomerulonephritis (HP:0000099) | 3.11349902 |
38 | Gangrene (HP:0100758) | 3.10194665 |
39 | Myocardial infarction (HP:0001658) | 3.10055261 |
40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04791929 |
41 | Amyloidosis (HP:0011034) | 3.01394969 |
42 | Hypergammaglobulinemia (HP:0010702) | 3.01197052 |
43 | Prolonged neonatal jaundice (HP:0006579) | 3.00394905 |
44 | Spontaneous hematomas (HP:0007420) | 2.94717724 |
45 | Increased IgM level (HP:0003496) | 2.93012648 |
46 | Vacuolated lymphocytes (HP:0001922) | 2.92242999 |
47 | Joint hemorrhage (HP:0005261) | 2.89943434 |
48 | Keratoconjunctivitis (HP:0001096) | 2.87558986 |
49 | Hematochezia (HP:0002573) | 2.86082194 |
50 | Chest pain (HP:0100749) | 2.85993780 |
51 | Urticaria (HP:0001025) | 2.83401269 |
52 | Abnormality of proline metabolism (HP:0010907) | 2.82853871 |
53 | Hydroxyprolinuria (HP:0003080) | 2.82853871 |
54 | Vasculitis (HP:0002633) | 2.81140479 |
55 | Orchitis (HP:0100796) | 2.78714150 |
56 | Porencephaly (HP:0002132) | 2.78315865 |
57 | Abnormality of complement system (HP:0005339) | 2.76943033 |
58 | Premature loss of primary teeth (HP:0006323) | 2.73169190 |
59 | Prostate neoplasm (HP:0100787) | 2.72728740 |
60 | Chronic sinusitis (HP:0011109) | 2.67698098 |
61 | Meningitis (HP:0001287) | 2.67288639 |
62 | Nephritis (HP:0000123) | 2.66592093 |
63 | Xanthomatosis (HP:0000991) | 2.64766073 |
64 | Abnormality of the prostate (HP:0008775) | 2.60620675 |
65 | Neurofibrillary tangles (HP:0002185) | 2.59338957 |
66 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55669151 |
67 | Pustule (HP:0200039) | 2.54862268 |
68 | Cellulitis (HP:0100658) | 2.52080151 |
69 | Gingival bleeding (HP:0000225) | 2.46466391 |
70 | Amaurosis fugax (HP:0100576) | 2.46309627 |
71 | Arterial thrombosis (HP:0004420) | 2.42848665 |
72 | Encephalitis (HP:0002383) | 2.42246587 |
73 | Recurrent bronchitis (HP:0002837) | 2.41872895 |
74 | Deep venous thrombosis (HP:0002625) | 2.41017077 |
75 | Hypertensive crisis (HP:0100735) | 2.37574671 |
76 | Esophageal varix (HP:0002040) | 2.36103084 |
77 | Esophageal neoplasm (HP:0100751) | 2.33517918 |
78 | Neoplasm of head and neck (HP:0012288) | 2.33517918 |
79 | Recurrent pneumonia (HP:0006532) | 2.31104350 |
80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.30824853 |
81 | Stomatitis (HP:0010280) | 2.29535815 |
82 | Disinhibition (HP:0000734) | 2.29022785 |
83 | Abnormality of the pleura (HP:0002103) | 2.27384256 |
84 | Hyperlipoproteinemia (HP:0010980) | 2.27204781 |
85 | Anorexia (HP:0002039) | 2.24394066 |
86 | Albinism (HP:0001022) | 2.22232452 |
87 | Hepatosplenomegaly (HP:0001433) | 2.21354472 |
88 | Global brain atrophy (HP:0002283) | 2.20904339 |
89 | Conjunctival telangiectasia (HP:0000524) | 2.19527243 |
90 | Emphysema (HP:0002097) | 2.19229906 |
91 | Colitis (HP:0002583) | 2.18404219 |
92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18182003 |
93 | Periodontitis (HP:0000704) | 2.17523301 |
94 | Abnormality of T cell number (HP:0011839) | 2.17356986 |
95 | Osteomyelitis (HP:0002754) | 2.16981384 |
96 | Purpura (HP:0000979) | 2.16370701 |
97 | Leukocytosis (HP:0001974) | 2.16113838 |
98 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.14703525 |
99 | Peritonitis (HP:0002586) | 2.14074574 |
100 | Dysostosis multiplex (HP:0000943) | 2.13561269 |
101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12960514 |
102 | Mucopolysacchariduria (HP:0008155) | 2.12960514 |
103 | Thin bony cortex (HP:0002753) | 2.11243688 |
104 | Axonal loss (HP:0003447) | 2.10605854 |
105 | Prolonged partial thromboplastin time (HP:0003645) | 2.09753247 |
106 | IgA deficiency (HP:0002720) | 2.09546236 |
107 | Intrahepatic cholestasis (HP:0001406) | 2.08698502 |
108 | Abnormality of the endocardium (HP:0004306) | 2.07832212 |
109 | Increased serum ferritin (HP:0003281) | 2.07372529 |
110 | Autoimmune hemolytic anemia (HP:0001890) | 2.07244007 |
111 | Lower limb hyperreflexia (HP:0002395) | 2.05178390 |
112 | Stomach cancer (HP:0012126) | 2.04009894 |
113 | Cheilitis (HP:0100825) | 2.03417114 |
114 | T lymphocytopenia (HP:0005403) | 2.03396250 |
115 | Bone pain (HP:0002653) | 2.03389766 |
116 | Epidermoid cyst (HP:0200040) | 2.03125156 |
117 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02501400 |
118 | Joint swelling (HP:0001386) | 2.01273966 |
119 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00484163 |
120 | Retrobulbar optic neuritis (HP:0100654) | 1.98236963 |
121 | Optic neuritis (HP:0100653) | 1.98236963 |
122 | Gastrointestinal stroma tumor (HP:0100723) | 1.98078481 |
123 | Inflammation of the large intestine (HP:0002037) | 1.96367928 |
124 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96354596 |
125 | Abnormality of the pericardium (HP:0001697) | 1.95830368 |
126 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95412154 |
127 | Restrictive lung disease (HP:0002091) | 1.95406679 |
128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94815965 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94815965 |
130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94815965 |
131 | Abnormality of iron homeostasis (HP:0011031) | 1.94732908 |
132 | Cerebral inclusion bodies (HP:0100314) | 1.94066131 |
133 | Chronic diarrhea (HP:0002028) | 1.93254670 |
134 | Skin ulcer (HP:0200042) | 1.93203506 |
135 | Pulmonary embolism (HP:0002204) | 1.93143087 |
136 | Hypophosphatemia (HP:0002148) | 1.92939518 |
137 | Progressive visual loss (HP:0000529) | 1.91789574 |
138 | Abnormality of T cell physiology (HP:0011840) | 1.91551505 |
139 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91375660 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 6.55042419 |
2 | TBK1 | 4.36944836 |
3 | TYK2 | 4.10543385 |
4 | IKBKE | 3.84114178 |
5 | FGFR4 | 3.72532755 |
6 | MAP3K14 | 3.15718890 |
7 | PIM2 | 3.02808127 |
8 | KIT | 2.96148165 |
9 | BLK | 2.83193081 |
10 | ERN1 | 2.82016031 |
11 | JAK1 | 2.80977466 |
12 | IRAK4 | 2.69315129 |
13 | TAOK3 | 2.52303747 |
14 | DDR2 | 2.45089471 |
15 | EPHB1 | 2.26840196 |
16 | JAK3 | 2.26200172 |
17 | EPHA3 | 2.20836870 |
18 | FGFR3 | 2.02712556 |
19 | PRPF4B | 2.02365366 |
20 | CDC42BPA | 1.88326453 |
21 | IRAK3 | 1.70903422 |
22 | DYRK1B | 1.70205099 |
23 | RIPK4 | 1.57795509 |
24 | IKBKB | 1.46250613 |
25 | MAP3K5 | 1.45951139 |
26 | IRAK1 | 1.32600405 |
27 | DMPK | 1.27141963 |
28 | JAK2 | 1.16650935 |
29 | CHUK | 1.11780921 |
30 | CSK | 1.10499369 |
31 | TAOK2 | 1.08952281 |
32 | ABL2 | 1.08601140 |
33 | FGR | 1.07552331 |
34 | CDK6 | 1.01304390 |
35 | STK4 | 0.99015084 |
36 | DAPK3 | 0.91467380 |
37 | FES | 0.91055785 |
38 | BMX | 0.90110720 |
39 | MAP3K13 | 0.85967658 |
40 | LCK | 0.84881795 |
41 | ACVR1B | 0.82428706 |
42 | EIF2AK2 | 0.82204584 |
43 | RIPK1 | 0.78693817 |
44 | RPS6KA4 | 0.78221563 |
45 | MAP3K11 | 0.75066564 |
46 | EGFR | 0.73088280 |
47 | TESK2 | 0.72368672 |
48 | HCK | 0.71874992 |
49 | SYK | 0.71656866 |
50 | MAP3K3 | 0.70537050 |
51 | TGFBR2 | 0.70516197 |
52 | TAOK1 | 0.69299294 |
53 | PDGFRA | 0.69091376 |
54 | MATK | 0.67953458 |
55 | LYN | 0.67286112 |
56 | NLK | 0.65519960 |
57 | SIK3 | 0.63467150 |
58 | TYRO3 | 0.59783040 |
59 | GRK7 | 0.59691823 |
60 | MAP4K1 | 0.59211975 |
61 | MAPK11 | 0.58376761 |
62 | ALK | 0.57922756 |
63 | EPHB2 | 0.56850068 |
64 | IRAK2 | 0.56533504 |
65 | CSF1R | 0.56529285 |
66 | PIM1 | 0.56325380 |
67 | MAPK4 | 0.55920302 |
68 | ABL1 | 0.55404242 |
69 | FER | 0.54919793 |
70 | DAPK2 | 0.53124584 |
71 | PTK6 | 0.51930714 |
72 | KDR | 0.51444168 |
73 | PKN1 | 0.50527805 |
74 | ZAP70 | 0.50088145 |
75 | SIK1 | 0.48538515 |
76 | TXK | 0.48412508 |
77 | CAMK1D | 0.47658050 |
78 | MST1R | 0.45168899 |
79 | TIE1 | 0.39566538 |
80 | ERBB2 | 0.39045726 |
81 | MAP3K12 | 0.38632637 |
82 | RPS6KA2 | 0.37477757 |
83 | STK10 | 0.37401347 |
84 | MAP2K3 | 0.37085858 |
85 | CLK1 | 0.37009662 |
86 | MAP3K1 | 0.36866694 |
87 | PRKG2 | 0.35665898 |
88 | PDK2 | 0.35414701 |
89 | RPS6KA5 | 0.34274168 |
90 | PDGFRB | 0.34028341 |
91 | HIPK2 | 0.33972597 |
92 | PRKCD | 0.33564325 |
93 | BTK | 0.33423804 |
94 | FYN | 0.33097308 |
95 | CDK4 | 0.32998702 |
96 | YES1 | 0.32295842 |
97 | MOS | 0.31886550 |
98 | PIK3CG | 0.30788233 |
99 | MAPKAPK2 | 0.30054395 |
100 | PRKCQ | 0.29459601 |
101 | NUAK1 | 0.29215663 |
102 | MAPK7 | 0.28986089 |
103 | BMPR2 | 0.28551653 |
104 | PDK1 | 0.28543000 |
105 | GSK3A | 0.27689370 |
106 | RPS6KL1 | 0.27408011 |
107 | RPS6KC1 | 0.27408011 |
108 | CAMK1G | 0.27235416 |
109 | TNK2 | 0.26518236 |
110 | PRKAA2 | 0.24835373 |
111 | CAMK2G | 0.24468069 |
112 | SRC | 0.24210964 |
113 | ITK | 0.24150626 |
114 | MARK3 | 0.22984122 |
115 | INSR | 0.22773202 |
116 | PHKG1 | 0.21923039 |
117 | PHKG2 | 0.21923039 |
118 | ERBB4 | 0.21683059 |
119 | RPS6KA6 | 0.20182216 |
120 | MST4 | 0.18880609 |
121 | TEC | 0.18783797 |
122 | SGK1 | 0.18559869 |
123 | MAPK3 | 0.17913864 |
124 | PDPK1 | 0.17901737 |
125 | LRRK2 | 0.17870288 |
126 | NME2 | 0.17593920 |
127 | LATS2 | 0.17051518 |
128 | RET | 0.16053001 |
129 | NEK9 | 0.15264667 |
130 | ADRBK2 | 0.14518415 |
131 | IGF1R | 0.13300409 |
132 | TTN | 0.12935616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.79334857 |
2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.24771146 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.65800512 |
4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.59686707 |
5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.41544108 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30507931 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24722053 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16586299 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.16318226 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.03781181 |
11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.02788056 |
12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.00140807 |
13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.99960734 |
14 | Measles_Homo sapiens_hsa05162 | 1.95441203 |
15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92387596 |
16 | Influenza A_Homo sapiens_hsa05164 | 1.87085847 |
17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86358026 |
18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74754692 |
19 | Hepatitis C_Homo sapiens_hsa05160 | 1.70460972 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.69203343 |
21 | Malaria_Homo sapiens_hsa05144 | 1.68056027 |
22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65169538 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64384068 |
24 | Lysosome_Homo sapiens_hsa04142 | 1.50329074 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49893308 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48179465 |
27 | Allograft rejection_Homo sapiens_hsa05330 | 1.46508984 |
28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40234032 |
29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39546046 |
30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33890181 |
31 | Phagosome_Homo sapiens_hsa04145 | 1.31207646 |
32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27312131 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21660711 |
34 | Asthma_Homo sapiens_hsa05310 | 1.18238252 |
35 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14401512 |
36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13831045 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13374875 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11107473 |
39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10610207 |
40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10009954 |
41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09003864 |
42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08549806 |
43 | Salmonella infection_Homo sapiens_hsa05132 | 1.07750255 |
44 | Legionellosis_Homo sapiens_hsa05134 | 1.06611961 |
45 | Peroxisome_Homo sapiens_hsa04146 | 1.04457306 |
46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04211253 |
47 | Apoptosis_Homo sapiens_hsa04210 | 1.02545745 |
48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02021498 |
49 | Hepatitis B_Homo sapiens_hsa05161 | 0.99943154 |
50 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98640664 |
51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98408530 |
52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98330345 |
53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94692139 |
54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92707381 |
55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91748165 |
56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88279358 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.82927211 |
58 | ABC transporters_Homo sapiens_hsa02010 | 0.82590501 |
59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80521301 |
60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80250684 |
61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77196630 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77003848 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71401802 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70811007 |
65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70510666 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.70039355 |
67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69546708 |
68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69054698 |
69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65268499 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63818537 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63059964 |
72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61895881 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60175161 |
74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59931070 |
75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59662666 |
76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58074283 |
77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56921284 |
78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55573578 |
79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54783221 |
80 | Prion diseases_Homo sapiens_hsa05020 | 0.54238536 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.53443442 |
82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52324657 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46239628 |
84 | Bile secretion_Homo sapiens_hsa04976 | 0.45805465 |
85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45072135 |
86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43712751 |
87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42968998 |
88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42330990 |
89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42161667 |
90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40125786 |
91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40058525 |
92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38666184 |
93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38549335 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.37690685 |
95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36521743 |
96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36153130 |
97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35742812 |
98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34779001 |
99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34245496 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33311042 |
101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32505040 |
102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32020834 |
103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31597680 |
104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31502753 |
105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30876959 |
106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30843023 |
107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30799729 |
108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29740637 |
109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27907072 |
110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27024053 |
111 | Bladder cancer_Homo sapiens_hsa05219 | 0.26660196 |
112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25214264 |
113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25176161 |
114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25054644 |
115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24688545 |
116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18478437 |
117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17606836 |
118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16796458 |
119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15694194 |
120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.15098946 |
121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13335542 |
122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11261784 |
123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10801811 |
124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.10057868 |
125 | Endocytosis_Homo sapiens_hsa04144 | 0.09382742 |
126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.09256748 |
127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.08547851 |
128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08519896 |
129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.07450478 |